China Asset Management Co., Ltd. increased its stake in 3SBIO (01530) by 1,492,500 shares, with a price of HK$28.1794 per share.
On January 13, Fullgoal Fund Management Co., Ltd. increased its holdings of Sisram Medical (01530) by 1,492,500 shares at a price of HKD 28.1794 per share, with a total amount of approximately HKD 420.578 million.
According to the latest data from the Hong Kong Stock Exchange, on January 13, Invesco Fund Management Limited increased its holdings of 3SBIO (01530) by 1.4925 million shares, with a price of HK$ 28.1794 per share, totaling approximately HK$ 420.578 million. The latest number of shares held after the increase is approximately 153 million shares, with the latest shareholding ratio at 6.02%.
Related Articles
SF Diamond Co., Ltd. (300179.SZ) several shareholders plan to collectively reduce their holdings by no more than 1.01% of the shares.
Liaoning He Eye Hospital Group (301103.SZ) shareholder Advanced Manufacturing Fund intends to reduce its shareholding by no more than 1.97%
Shanghai Huide Science & Technology (603192.SH) Stock issuance request approved by the registration approval.
SF Diamond Co., Ltd. (300179.SZ) several shareholders plan to collectively reduce their holdings by no more than 1.01% of the shares.
Liaoning He Eye Hospital Group (301103.SZ) shareholder Advanced Manufacturing Fund intends to reduce its shareholding by no more than 1.97%
Shanghai Huide Science & Technology (603192.SH) Stock issuance request approved by the registration approval.
